Glaukos Corporation (GKOS) vs Haemonetics Corporation (HAE)
- Glaukos Corporation GKOS 164.84 −0.46%
- Haemonetics Corporation HAE 118.28 −2.48%
Glaukos Corporation and Haemonetics Corporation are both Medical Devices companies. Glaukos Corporation is the larger, with a market value of $9.8B against $5.5B — 1.8× the size. Glaukos Corporation has negative trailing earnings, so its P/E is not meaningful; Haemonetics Corporation trades at 57.7×. Glaukos Corporation grew revenue faster over the last twelve months: 41.6% against 0.44%. Haemonetics Corporation has the higher net margin (7.12% vs −30.7%) and the higher return on invested capital (5.62% vs −26.1%). Across the 19 metrics below, Haemonetics Corporation leads on 12 and Glaukos Corporation on 7.
Valuation
Profitability
| Metric | GKOS | HAE | Medical Devices median |
|---|---|---|---|
| Gross margin | 79.12% | 59.03% | 56.01% |
| Operating margin | (31.55%) | 11.86% | (15.03%) |
| Net margin | (30.68%) | 7.12% | (20.40%) |
| Free cash flow margin | (1.99%) | 21.64% | (7.24%) |
| Return on equity | (25.98%) | 11.20% | (15.32%) |
| Return on assets | (19.72%) | 3.99% | (19.72%) |
| Return on invested capital | (26.07%) | 5.62% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack